Pharmaceutical Industry news

• MRI Measure May ID Men at Risk for Postradiation Genitourinary Toxicity

  01-12-2023 18:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- Longer prostatic urethral length measured on prostate magnetic resonance imaging (MRI) is independently associated with a higher risk for developing late genitourinary (GU) toxicity after radiation therapy (RT) for prostate...
  
  Read more

• Ichthyosis Tied to Increased Risk of Depression, Anxiety

  01-12-2023 18:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- Ichthyosis is associated with increased likelihood of depression and anxiety, according to a research letter published online Oct. 18 in the Journal of the American Academy of Dermatology. 
  Gloria Chen, from the...
  
  Read more

• Four JAK Inhibitors Have Comparable Efficacy, Safety for RA

  01-12-2023 18:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- For patients with rheumatoid arthritis, the efficacy and safety of four Janus kinase (JAK) inhibitors is comparable, according to a study published online Nov. 1 in Rheumatology.
  Shinya Hayashi, M.D., from the Kobe...
  
  Read more

• Thicker Choroid, Haller Layer Seen on Ipsilateral Side in Meniere Disease

  01-12-2023 17:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- Patients with Meniere disease (MD) have a thicker choroid and Haller layer on the ipsilateral side than controls, according to a study published online Nov. 2 in The Laryngoscope.
  Maliheh Akbarpour, M.D., from the Guilan...
  
  Read more

• Advertisement

• Mechanical Thrombectomy Safe, Effective for High-Risk Pulmonary Embolism

  01-12-2023 17:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- Mechanical thrombectomy (MT) is safe and effective in real-world, high-risk patients with pulmonary embolism (PE), according to a study published online Oct. 31 in the Journal of the Society for Cardiovascular...
  
  Read more

• High Systolic BP Tied to Higher Cardiovascular Mortality in T2DM

  01-12-2023 17:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- Clinic systolic blood pressure (BP) ≥130 mm Hg or diastolic BP levels ≥90 mm Hg are associated with a higher risk for cardiovascular disease (CVD) mortality in people with type 2 diabetes mellitus (T2DM),...
  
  Read more

• GERD Is Common Indication for Revisional Bariatric Surgery

  01-12-2023 17:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- For patients who have undergone bariatric surgery for gastroesophageal reflux disease (GERD), revision surgery is common and is mainly with a Roux-en-Y gastric bypass (RYGB), according to a study published online Oct. 31 in...
  
  Read more

• Diabetes Tied to Identifiable Vocal Changes

  01-12-2023 17:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- Vocal changes appear to occur in individuals with type 2 diabetes mellitus (T2DM) versus those without diabetes, according to a study published online in the December issue of Mayo Clinic Proceedings: Digital...
  
  Read more

• Advertisement

• Clot Risk High With Oral Contraceptives for Those at Genetic Risk

  01-12-2023 17:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- Oral contraceptive (OC) use is associated with an increased risk for developing a venous thromboembolism (VTE), particularly among women with a high genetic predisposition, according to a study recently published online in...
  
  Read more

• ASTRO Issues Guidance Related to Partial Breast Irradiation

  01-12-2023 17:12 via drugs.com
  
  FRIDAY, Dec. 1, 2023 -- In a clinical practice guideline issued by the American Society for Radiation Oncology (ASTRO) published online Nov. 15 in Practical Radiation Oncology, recommendations are presented to inform best clinical practices on the...
  
  Read more

• UK Biobank reveals new data from world's largest genetic project

  01-12-2023 13:35
  
  The data will accelerate the development of potentially lifesaving treatments and cures
  
  Read more

• AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition

  01-12-2023 13:35
  The agreement grants the company access to ImmunoGen’s FDA-approved ovarian cancer drug Elahere
  
  Read more

• New study finds dose of subcutaneous cladribine could predict MS relapse risk

  01-12-2023 13:34
  
  The disease affects approximately 130,000 people in the UK and currently has no cure
  
  Read more

• Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant

  01-12-2023 13:34
  
  Vasomotor symptoms affect up to 80% of menopausal women in the US
  
  Read more

• GSK global survey reveals misunderstandings about shingles in adults

  01-12-2023 13:33
  
  About 55% of respondents believe that shingles can be caught from someone else
  
  Read more

Follow @PharmaIndustry_ on Twitter!